Brief: Ani Pharmaceuticals Announces FDA Approval And Launch Of Isosorbide Mononitrate Tablet
08/04/2026 13:10
April 8 (Reuters) - ANI Pharmaceuticals Inc ANIP.O: ANI PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND LAUNCH OF ISOSORBIDE MONONITRATE TABLET Source text: ID:nGNX5hRwsx Further company coverage: ANIP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma